Cargando…

Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis

CONTEXT: Transsphenoidal neurosurgery is the accepted first-line treatment of acromegaly in the majority of patients. Previous studies addressing preoperative somatostatin analog (SSA) treatment and subsequent surgical cure rates are conflicting, reporting either benefits or no significant differenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pita-Gutierrez, Francisco, Pertega-Diaz, Sonia, Pita-Fernandez, Salvador, Pena, Lara, Lugo, Gloria, Sangiao-Alvarellos, Susana, Cordido, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636268/ https://www.ncbi.nlm.nih.gov/pubmed/23634209 http://dx.doi.org/10.1371/journal.pone.0061523

Ejemplares similares

Clinical Manifestations and Diagnosis of Acromegaly
por: Lugo, Gloria, et al.
Publicado: (2012)

Effect of Oral Glucose Administration on Rebound Growth Hormone Release in Normal and Obese Women: The Role of Adiposity, Insulin Sensitivity and Ghrelin
por: Pena-Bello, Lara, et al.
Publicado: (2015)

Effect of Ghrelin on Glucose-Insulin Homeostasis: Therapeutic Implications
por: Sangiao-Alvarellos, Susana, et al.
Publicado: (2010)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects
por: Pena-Bello, Lara, et al.
Publicado: (2016)

Evaluation of Thyroid Hormone Replacement Dosing in Morbidly Obese Hypothyroid Patients after Bariatric Surgery-Induced Weight Loss
por: Juiz-Valiña, Paula, et al.
Publicado: (2021)

Altered GH-IGF-1 Axis in Severe Obese Subjects is Reversed after Bariatric Surgery-Induced Weight Loss and Related with Low-Grade Chronic Inflammation
por: Juiz-Valiña, Paula, et al.
Publicado: (2020)

Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Euthyroid Patients with Morbid Obesity
por: Juiz-Valiña, Paula, et al.
Publicado: (2019)

Central Resistance to Thyroid Hormones in Morbidly Obese Subjects Is Reversed after Bariatric Surgery-Induced Weight Loss
por: Juiz-Valiña, Paula, et al.
Publicado: (2020)

Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks
por: Díez, Juan J., et al.
Publicado: (2018)

Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
por: Cordido, María, et al.
Publicado: (2022)

The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
por: Cordido, Fernando, et al.
Publicado: (2010)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
por: Machado-Alba, J. E., et al.
Publicado: (2022)

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review
por: Heidarpour, Maryam, et al.
Publicado: (2019)

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs
por: Daniel, Charles P., et al.
Publicado: (2023)

Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature
por: Kizilgul, Muhammed, et al.
Publicado: (2022)

The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021)

FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle
por: Varela-Rodríguez, B. M., et al.
Publicado: (2016)

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients
por: Neggers, Sebastian J. C. M. M., et al.
Publicado: (2011)

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
por: Gurel, Michelle H., et al.
Publicado: (2017)

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
por: Gadelha, Mônica, et al.
Publicado: (2020)

Identification of predictive factors of the degree of adherence to the Mediterranean diet through machine-learning techniques
por: Arceo-Vilas, Alba, et al.
Publicado: (2020)

MiR-19 Family Impairs Adipogenesis by the Downregulation of the PPARγ Transcriptional Network
por: Juiz-Valiña, Paula, et al.
Publicado: (2022)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Novel Somatostatin Receptor Ligands Therapies for Acromegaly
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD
por: Blanco-Aparicio, Marina, et al.
Publicado: (2013)

Clinical-Pathological Characteristics and Prognosis of a Cohort of Oesophageal Cancer Patients: a Competing Risks Survival Analysis
por: Rodríguez-Camacho, Elena, et al.
Publicado: (2015)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Glycemic profile in patients with acromegaly treated with somatostatin analogue
por: Valea, A, et al.
Publicado: (2015)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly
por: Kontogeorgos, George, et al.
Publicado: (2022)

AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients
por: Daly, Adrian F, et al.
Publicado: (2019)

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study
por: Kuhn, Emmanuelle, et al.
Publicado: (2020)

Cancer incidence in kidney transplant recipients: a study protocol
por: Pita-Fernandez, Salvador, et al.
Publicado: (2009)

Preoperative Somatostatin Analogues in Patients with Newly-diagnosed Acromegaly: A Systematic Review and Meta-analysis of Comparative Studies
por: Yang, Chengxian, et al.
Publicado: (2019)

Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study
por: Kuhn, Emmanuelle, et al.
Publicado: (2020)

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review
por: Cella, David, et al.
Publicado: (2021)

E‐cadherin expression is associated with somatostatin analogue response in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2019)

Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
por: Gil, Joan, et al.
Publicado: (2021)

Respiratory physiotherapy and incidence of pulmonary complications in off-pump coronary artery bypass graft surgery: an observational follow-up study
por: Yánez-Brage, Isabel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_32fc6is4d41b9u6sbohnlkn8st